Skip to Main Content

CERSI Obtains FDA Grant Renewal

November 16, 2018
by Julie Parry

Joseph S. Ross, MD, MHS, associate professor of medicine (general medicine) and public health (health policy and management) was awarded a U.S. Food & Drug Administration (FDA) grant renewal up to $20M for work on the Yale-Mayo Clinic FDA Center of Excellence in Regulatory Science and Innovation (CERSI). The grant was recently renewed for years three through seven.

Almost three years ago, Ross and a colleague at Mayo Clinic submitted a proposal to the FDA, which was approved and led to the creation of the CERSI. The CERSI consists of faculty at Yale, Mayo Clinic and the FDA. Currently, the team has nine open projects ranging from opioid use and generic drug efficacy to the use of an app for medical device surveillance.   

“What I like most about our CERSI is that the work we do is very collaborative,” said Ross. “We try to pursue every project so there is a lead at Yale and Mayo Clinic, which strengthens the work between the two institutions. Additionally, folks from across Yale participate. These are true cooperative projects. I am always very cognizant of doing work to inform policy makers and have an impact. I like working together with agency officials to try to figure out what they need to know.”  

The Yale-Mayo Clinic FDA CERSI operates as a component of the Center for Outcomes Research & Evaluation (CORE) at Yale School of Medicine. 

Submitted by Julie Parry on November 16, 2018